Log in to your Inderes Free account to see all free content on this page.
Alligator Bioscience
0.42 SEK
+8.85 %
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+8.85 %
-26.62 %
-63.89 %
-63.65 %
-92.91 %
-92.92 %
-98.34 %
-99.53 %
-99.91 %
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
275.5M SEK
Turnover
1.11M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2.
2026
Annual report '25
6.5.
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Alligator Bioscience publishes financial calendar for 2026
Alligator Bioscience enters into additional subscription undertakings and top guarantee commitments for the upcoming rights issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio